Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001000666 | SCV001006485 | benign | Cerebral cavernous malformation 2 | 2023-12-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001000666 | SCV001157696 | benign | Cerebral cavernous malformation 2 | 2021-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381934 | SCV002693205 | likely benign | Inborn genetic diseases | 2022-03-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV001000666 | SCV002804906 | likely benign | Cerebral cavernous malformation 2 | 2022-05-11 | criteria provided, single submitter | clinical testing |